Myelodysplastic syndrome with multilineage dysplasia evolving to acute myeloid leukemia: Noonan syndrome with c.218C>T mutation in PTPN11
 gene

Rathika Damodara Shenoy; Sunil Kumar Yeshvanth; Harsha Prasada L; Vijaya Shenoy; Vikram Shetty

doi:10.1002/pbc.27527

Myelodysplastic syndrome with multilineage dysplasia evolving to acute myeloid leukemia: Noonan syndrome with c.218C>T mutation in PTPN11 gene

Pediatric Blood & Cancer ◽

10.1002/pbc.27527 ◽

2018 ◽

Vol 66 (2) ◽

pp. e27527 ◽

Cited By ~ 1

Author(s):

Rathika Damodara Shenoy ◽

Sunil Kumar Yeshvanth ◽

Harsha Prasada L ◽

Vijaya Shenoy ◽

Vikram Shetty

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Noonan Syndrome ◽

Myeloid Leukemia ◽

Ptpn11 Gene ◽

Multilineage Dysplasia ◽

Acute Myeloid

Download Full-text

Marrow Fibrosis as a Risk Factor for Posttransplantation Outcome in Patients with Advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia with Multilineage Dysplasia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2006.10.030 ◽

2007 ◽

Vol 13 (3) ◽

pp. 345-354 ◽

Cited By ~ 33

Author(s):

Bart L. Scott ◽

Barry E. Storer ◽

Joanne E. Greene ◽

Robert C. Hackman ◽

Frederick R. Appelbaum ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Risk Factor ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Multilineage Dysplasia ◽

Marrow Fibrosis ◽

Acute Myeloid

Download Full-text

Decision letter for "The Incidence, Risk Factors and Survival of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome: A Population‐Based Study"

10.1002/hon.2660/v3/decision1 ◽

2019 ◽

Keyword(s):

Risk Factors ◽

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Population Based ◽

Population Based Study ◽

Incidence Risk ◽

Acute Myeloid

Download Full-text

Author response for "The Incidence, Risk Factors and Survival of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome: A Population‐Based Study"

10.1002/hon.2660/v2/response1 ◽

2019 ◽

Author(s):

Xingnong Ye ◽

Dan Chen ◽

Yan Zheng ◽

Cai Wu ◽

Xiaoqiong Zhu ◽

...

Keyword(s):

Risk Factors ◽

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Population Based ◽

Author Response ◽

Population Based Study ◽

Incidence Risk ◽

Acute Myeloid

Download Full-text

Decision letter for "The Incidence, Risk Factors and Survival of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome: A Population‐Based Study"

10.1002/hon.2660/v2/decision1 ◽

2019 ◽

Keyword(s):

Risk Factors ◽

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Population Based ◽

Population Based Study ◽

Incidence Risk ◽

Acute Myeloid

Download Full-text

Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome

10.32388/p7v2fx ◽

2020 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Alkylating Agent ◽

Acute Myeloid

Download Full-text

HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)

Case Medical Research ◽

10.31525/ct1-nct03940352 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Acute Myeloid

Download Full-text

Pembrolizumab and Decitabine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory

Case Medical Research ◽

10.31525/ct1-nct03969446 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Newly Diagnosed ◽

Acute Myeloid

Download Full-text

Faculty Opinions recommendation of Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10197.467594 ◽

2006 ◽

Author(s):

Mayumi Mori

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Prognostic Models ◽

Intensive Chemotherapy ◽

Acute Myeloid

Download Full-text

Faculty Opinions recommendation of A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1119427.575617 ◽

2008 ◽

Author(s):

Arati Rao

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Low Dose ◽

Randomized Study ◽

Front Line ◽

Line Therapy ◽

Low Dose Cytarabine ◽

Acute Myeloid

Download Full-text

Faculty Opinions recommendation of Isavuconazole as Primary Anti-Fungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective, Phase II Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737669231.793578956 ◽

2020 ◽

Author(s):

Livio Pagano

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Open Label ◽

Prospective Phase ◽

Anti Fungal ◽

Acute Myeloid

Download Full-text